Adenosine Injection, Solution
Product Images NDC 51662-1632

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Adenosine (NDC 51662-1632). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Label (51662 1632 1 Serialized Labeling)

A close-up label section of ADENOSINE injection solution showing serialized numeric codes related to product identification and tracking, a barcode, and text indicating the product is distributed by HF Acquisition Co., LLC in Mukilteo, WA. The label includes the instruction to see the manufacturer's package insert and has 'RX ONLY' printed vertically.*

FDA Label Image

Structure (Structure)

Chemical structure of Adenosine showing its molecular formula C10H13N5O4 and molecular weight 267.25. The diagram depicts the arrangement of atoms in the compound, including the adenine base attached to a ribose sugar moiety.*

FDA Label Image

Vial Label (Vial Label Single Dose)

Label of ADENOSINE Injection, USP, 6 mg per 2 mL solution (3 mg/mL) in a single-dose 2 mL vial. The label states it is for rapid bolus intravenous use with usual dosage instructions referring to the insert. It advises not to refrigerate and is marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.